Anna Binda

Via Cadore, 48
Monza, 20900, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights.

Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights.

Journal: International journal of molecular sciences

Published: September 08, 2023

A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet.

A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet.

Journal: Epilepsia

Published: July 13, 2023

Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes.

Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes.

Journal: Frontiers in pharmacology

Published: February 09, 2022

Novel SCN5A p.Val1667Asp Missense Variant Segregation and Characterization in a Family with Severe Brugada Syndrome and Multiple Sudden Deaths.

Novel SCN5A p.Val1667Asp Missense Variant Segregation and Characterization in a Family with Severe Brugada Syndrome and Multiple Sudden Deaths.

Journal: International journal of molecular sciences

Published: April 08, 2021

Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients?

Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients?

Journal: Progress in biophysics and molecular biology

Published: March 04, 2021

Effect of the ketogenic diet in excitable tissues.

Effect of the ketogenic diet in excitable tissues.

Journal: American journal of physiology. Cell physiology

Published: January 27, 2021

Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy.

Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy.

Journal: Pharmacological research

Published: July 30, 2020

Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer's Disease: A State-of-the-Art (2017-2020).

Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer's Disease: A State-of-the-Art (2017-2020).

Journal: International journal of nanomedicine

Published: April 16, 2020

GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death.

GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death.

Journal: EBioMedicine

Published: March 11, 2020

Rational design of a mutation to investigate the role of the brain protein TRIP8b in limiting the cAMP response of HCN channels in neurons.

Rational design of a mutation to investigate the role of the brain protein TRIP8b in limiting the cAMP response of HCN channels in neurons.

Journal: The Journal of general physiology

Published: February 26, 2020

Cardiac and neuronal HCN channelopathies.

Cardiac and neuronal HCN channelopathies.

Journal: Pflugers Archiv : European journal of physiology

Published: February 19, 2020

HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature.

HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature.

Journal: Epilepsy research

Published: March 07, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026